Evidence map›Paper›PMID 35911387›Full record

ArticleFrontiers in medicine2022

Prevalence of Long COVID-19 Symptoms After Hospital Discharge in Frail and Robust Patients.

Sarah Damanti, Marta Cilla, Maria Cilona, Aldo Fici, Aurora Merolla, Giacomo Pacioni, Rebecca De Lorenzo, Sabina Martinenghi, Giordano Vitali, Cristiano Magnaghi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Sarah DamantiUnit of General Medicine and Advanced Care, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Institute, Milan, Italy.
Marta CillaUnit of General Medicine and Advanced Care, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Institute, Milan, Italy.
Maria CilonaFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Aldo FiciFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Aurora MerollaFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Giacomo PacioniFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Rebecca De LorenzoFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Sabina MartinenghiSan Raffaele Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Giordano VitaliSan Raffaele Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Cristiano MagnaghiDepartment of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
Anna FumagalliCOVID Trial Unit, Department of Internal Medicine, IRCCS San Raffaele Institute, Milan, Italy.
Mario Gennaro MazzaFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Francesco BenedettiFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Moreno TresoldiUnit of General Medicine and Advanced Care, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Institute, Milan, Italy.
Patrizia Rovere QueriniFaculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Vita-Salute San Raffaele University · ITIRCCS Ospedale San Raffaele · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A motley postacute symptomatology may develop after COVID-19, irrespective of the acute disease severity, age, and comorbidities. Frail individuals have reduced physiological reserves and manifested a worse COVID-19 course, during the acute setting. However, it is still unknown, whether frailty may subtend some long COVID-19 manifestations. We explored the prevalence of long COVID-19 disturbs in COVID-19 survivals. Methods: This was an observational study. Patients aged 65 years or older were followed-up 1, 3, and 6 months after hospitalization for COVID-19 pneumonia. Results: A total of 382 patients were enrolled. Frail patients were more malnourished (median Mini Nutritional Assessment Short Form score 8 vs. 9, Conclusion: The precocious identification of frail COVID-19 survivors, who manifest more motor and respiratory complaints during the follow-up, could improve the long-term management of these COVID-19 sequelae.

Indexed as

COVID-19frailtylong COVID-19 syndromeolder peopleprevalence

Identifiers

PMID35911387
PMCPMC9329529
OpenAlexW4285389365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.